Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan
· Delayed Price · Currency is TWD 788.00
-57.00 (-6.75%)
At close: Mar 31, 2025
TPE:6919 Market Cap
TPE:6919 has a market cap or net worth of 121.22 billion as of March 31, 2025. Its market cap has increased by 255.18% in one year.
Market Cap
121.22B
Enterprise Value
111.56B
Revenue
44.43M
Ranking
n/a
PE Ratio
n/a
Stock Price
788.00
Market Cap Chart
Since December 26, 2022, TPE:6919's market cap has increased from 7.96B to 121.22B, an increase of 1,423.13%. That is a compound annual growth rate of 233.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 121.22B | 28.46% |
| Dec 31, 2024 | 94.36B | 300.87% |
| Dec 29, 2023 | 23.54B | 212.69% |
| Dec 30, 2022 | 7.53B | -5.41% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 185.17B |
| Bora Pharmaceuticals Co., LTD. | 74.15B |
| Lotus Pharmaceutical | 64.08B |
| Oneness Biotech | 33.46B |
| Lumosa Therapeutics | 31.92B |
| Pegavision | 29.52B |
| Polaris Group | 28.92B |
| Center Laboratories | 27.66B |